(1R,8R,11R)‐3,3,11‐Tri­methyl‐6,6‐ethyl­ene­dioxy­bi­cyclo­[6.3.0]­undecan‐2‐one and (1R,2R,8R,11R)‐3,3,11‐tri­methyl‐6,6‐ethylenedioxybicyclo[6.3.0]undecan‐2‐ol

The reduction of (1R,8R,11R)‐3,3,11‐tri­methyl‐6,6‐ethyl­ene­dioxy­bi­cyclo­[6.3.0]­undecan‐2‐one, C₁₆H₂₆O₃, (I), gave exclusively an alcohol, C₁₆H₂₈O₃, (II). The stereochemistry of the hydroxyl group in (II) was shown as R. The conformation around the eight‐membered carbocycle in (I) differs markedly from that in (II).     

New electron‐deficient chiral phosphines: (4R,5R)‐1,3‐bis(trifluoromethanesulfonyl)perhydro‐1,3,2‐benzodiazaphosphol‐2‐yl] substituted amines

Three chiral electron‐deficient phosphine ligands, [(4R,15R)‐,3‐bis­(tri­fluoro­methane­sulfonyl)­per­hydro‐1,3,2‐benzodiazaphosphol‐2‐yl]­diethyl­amine, C₁₂H₂₀F₆N₃O₄PS₂, (IIIa), [(4R,5R)‐1,3‐bis­(tri­fluoro­methane­sulfonyl)­per­hydro‐1,3,2‐benzodi­aza­phosphol‐2‐yl]­di­methyl­amine, C₁₀H₁₆F₆N₃O₄PS₂, (IIIb), and bis­[(4R,5R)‐1,3‐bis­(tri­fluoro­methane­sulfonyl)­per­hydro‐1,3,2‐benzodi­aza­phosphol‐2‐yl]­methyl­amine, (IV), as the chloroform solvate, C₁₇H₂₃F₁₂N₅O₈P₂S₄·0.98CHCl₃, have been prepared from (1R,2R)‐N,N′‐bis­(tri­fluoro­methane­sulfonyl)‐1,2‐cyclo­hexane­di­amine and diethyl phosphor­amido­us dichloride, dimethyl phosphoramidous dichloride or methyl imidodi­phosphorus tetrachloride. The π‐acceptor abilities of these new types of ligands have been evaluated by X‐ray determination of the P—N bond lengths; it has been found that the most promising ligand is the bis­(phosphine) (IV).     

The absolute configuration of (2S,4S)‐ and (2R,4R)‐2‐tert‐butyl‐4‐methyl‐3‐(4‐tolyl­sulfon­yl)‐1,3‐oxazolidine‐4‐carbaldehyde

The title enanti­omorphic compounds, C₁₆H₂₃NO₄S, have been obtained in an enanti­omerically pure form by crystallization from a diastereomeric mixture either of (2S,4S)‐ and (2R,4S)‐ or of (2R,4R)‐ and (2S,4R)‐2‐tert‐butyl‐4‐methyl‐3‐(4‐tolyl­sulfon­yl)‐1,3‐oxazolidine‐4‐carbaldehyde. These mixtures were prepared by an aziridination rearrangement process starting with (S)‐ or (R)‐2‐tert‐butyl‐5‐methyl‐4H‐1,3‐dioxine. The crystal structures indicate an envelope conformation of the oxazolidine moiety for both compounds.     

(3R*,3′R*)‐1,1′‐Dimethyl‐3,3′‐biindoline‐2,2′‐dithione

The (3R*,3′R*) configuration of the title compound, C₁₈H₁₆N₂S₂, (I), has been unambiguously elucidated by X‐­ray analysis. Mol­ecules of (I) have C₂ symmetry to a good approximation and a strongly folded shape. The interplanar angle between the two halves of a mol­ecule is 67.11 (6)°.     

The diastereoisomers methyl 5‐(S)‐[2‐(R)/(S)‐methoxycarbonyl)‐2,3,4,5‐tetrahydropyrrol‐1‐ylcarbonyl]‐1‐(4‐methylphenyl)‐4,5‐dihydropyrazole‐3‐carboxylate

The title diastereoisomers, methyl 5‐(S)‐[2‐(S)‐methoxy­carbonyl)‐2,3,4,5‐tetra­hydro­pyrrol‐1‐yl­carbonyl]‐1‐(4‐methyl­phenyl)‐4,5‐di­hydro­pyrazole‐3‐carboxyl­ate and methyl 5‐(S)‐[2‐(R)‐methoxycarbonyl)‐2,3,4,5‐tetrahydropyrrol‐1‐ylcarbonyl]‐1‐(4‐methyl­phenyl)‐4,5‐di­hydro­pyrazole‐3‐carboxylate, both C₁₉H₂₃N₃O₅, have been studied in two crystalline forms. The first form, methyl 5‐(S)‐[2‐(S)‐methoxy­carbonyl)‐2,3,4,5‐tetrahydropyrrol‐1‐ylcarbonyl]‐1‐(4‐methylphenyl)‐4,5‐di­hydro­pyrazole‐3‐carboxyl­ate–methyl 5‐(S)‐[2‐(R)‐methoxy­carbonyl)‐2,3,4,5‐tetra­hydro­pyrrol‐1‐yl­carbonyl]‐1‐(4‐methylphenyl)‐4,5‐dihydropyrazole‐3‐carboxylate (1/1), 2(S),5(S)‐C₁₉H₂₃N₃O₅·2(R),5(S)‐C₁₉H₂₃N₃O₅, contains both S,S and S,R isomers, while the second, methyl 5‐(S)‐[2‐(S)‐methoxycarbonyl)‐2,3,4,5‐tetrahydro­pyrrol‐1‐ylcarbonyl]‐1‐(4‐methyl­phenyl)‐4,5‐di­hydro­pyrazole‐3‐carboxyl­ate, 2(S),5(S)‐C₁₉H₂₃N₃O₅, is the pure S,S isomer. The S,S isomers in the two structures show very similar geometries, the maximum difference being about 15° on one torsion angle. The differences between the S,S and S,R isomers, apart from those due to the inversion of one chiral centre, are more remarkable, and are partially due to a possible rotational disorder of the 2‐­(methoxycarbonyl)tetrahydropyrrole group.     

Two (+)‐α,4‐dimethyl‐2‐oxocyclo­hexaneacetic acids: hydrogen bonding in a terpenoid γ‐keto acid and in a diastereomeric lactol

The (+)‐(αS,1S,4R)‐diastereomer of the title structure, C₁₀H₁₆O₃, aggregates in the solid as non‐symmetric dimers with disorder in both carboxyl groups [O·O = 2.710 (5) and 2.638 (5) Å]. The two mol­ecules constituting the asymmetric unit pair around a pseudo‐twofold rotational axis and differ only slightly in their distances and angles, but one methyl group displays rotational disorder absent in the other mol­ecule. Five inter­molecular C—H·O close contacts exist, involving both ketone groups. The (+)‐(αR,1R,4R)‐diastereomer exists in the crystal in its closed‐ring lactol form, (3R,3aR,6R,7aR)‐2,3,3a,4,5,6,7,7a‐octa­hydro‐7a‐hydroxy‐3,6‐dimethyl­benzo[b]furan‐2‐one, C₁₀H₁₆O₃, and aggregates as hydrogen‐bonded catemers that extend from the hydroxyl group of one mol­ecule to the carbonyl group of a neighbor screw‐related along b [O·O = 2.830 (3) Å and O—H·O = 169°]. One close inter­molecular C—H·O contact exists involving the carbonyl group.     

Tolterodinium (+)‐(2R,3R)‐hydrogen tartrate

In the crystal structure of (R)‐N,N‐diisopropyl‐3‐(2‐hydroxy‐5‐methyl­phenyl)‐3‐phenyl­propyl­aminium (2R,3R)‐hydrogen tartrate, C₂₂H₃₂NO⁺·C₄H₅O₆⁻, the hydrogen tartrate anions are linked by O—H⋯O hydrogen bonds to form helical chains built from (9) rings. These chains are linked by the tolterodine molecules via N—H⋯O and O—H⋯O hydrogen bonds to form separate sheets parallel to the (101) plane.     

(5S*,6R*)‐1,7‐Dioxa­di­spiro­[4.0.4.4]­tetra­decane‐2,8‐dione

The title compound, C₁₂H₁₆O₄, (I), was prepared by oxidation of (5S*,6R*)‐1,7‐di­oxa­di­spiro­[4.0.4.4]­tetra­decane‐2,8‐diol us­ing silver(I) carbonate and posesses a cis configuration of the two five‐membered‐ring lactones fused spiro to the six‐membered carbocycle, which has a chair conformation. It represents an exceptional structure for bis‐tetra­hydro­furan units, which are interesting building blocks in natural products. The synthesis, spectroscopic data and X‐ray structural analysis are described. The crystal contains discrete mol­ecules separated by normal van der Waals distances.     

Absolute configuration of (−)‐4‐(3,4‐di­chloro­phenyl)‐4‐(2‐pyridyl)­butanoic acid: essential information to determine crucial steric features of ­arpromidine‐type hist­amine H2 receptor agonists

The structural information gained from the study of the chiral building block (R)‐(?)‐4‐(3,4‐di­chloro­phenyl)‐4‐(2‐pyridyl)­butanoic acid–l ‐(?)‐ephedrine [methyl(1‐hydroxy‐1‐phenyl­prop‐2‐yl)ammon­ium 4‐(3,4‐di­chloro­phenyl)‐4‐(2‐pyrid­yl)but­an­oate], C₁₀H₁₆NO⁺·C₁₅H₁₂Cl₂NO₂^?, can be used to deduce the absolute configuration of highly potent arpromidine‐type hist­amine H₂ receptor agonists, as the chiral butanoic acid can be converted to (R)‐(?)‐3‐(3,4‐di­chloro­phenyl)‐3‐(2‐pyridyl)­propyl­amine and to the corresponding R‐configured arpromidine analogue.     

Hydrogen bonding in C‐substituted nitroanilines: molecular ladders in 2‐trifluoromethyl‐4‐nitroaniline and sheets of R(12) and R(32) rings in 3‐trifluoromethyl‐4‐nitroaniline

In 2‐tri­fluoro­methyl‐4‐nitro­aniline, C₇H₅F₃N₂O₂, (I), the mol­ecules lie across a mirror plane in space group Pnma. The mol­ecules are linked by paired N—H?O hydrogen bonds to form a C(8)[R(6)] chain of rings, pairs of which are linked into a molecular ladder by a single C—H?O hydrogen bond. The isomeric 3‐tri­fluoro­methyl‐4‐nitro­aniline, (II), has Z′ = 2 in space group P2₁/c. Each mol­ecule is linked to four others by N—H?O hydrogen bonds to form sheets built from alternating R(12) and R(32) rings.     

9(R)‐[6(R)‐Hydroxy­methyl‐1‐oxa‐4‐thia­cyclo­hexan‐2‐yl]hypoxanthine–water (4/3), a nucleoside analogue

The title compound, 9(R)‐[6(R)‐hydroxy­methyl‐1‐oxa‐4‐thia­cyclo­hexan‐2‐yl]‐1,9‐di­hydro‐6H‐purin‐6‐one–water (4/3), C₁₀H₁₂N₄O₃S·0.75H₂O, crystallizes in the triclinic space group P1 with four mol­ecules in the asymmetric unit and 0.75 waters of hydration per mol­ecule. The structure was refined to an R value of 0.072 for 3382 observed reflections. The four crystallographically independent mol­ecules are designated A, B, C and D. All four oxa­thia­ne rings adopt the chair conformation and the purine bases are in an anti orientation with respect to the sugar moieties. Molecules A and D and mol­ecules C and B are base paired by a single hydrogen bond of the type N—H?N. These base pairs are again hydrogen bonded to their translated pairs in the direction of a cell diagonal.     

(R)‐(+)‐2,2′‐Bis­(di­phenyl­phosphinoyl)‐1,1′‐bi­naphthyl

The title compound, BINAP oxide, C₄₄H₃₂O₂P₂, (I), was synthesized by direct oxidation of (R)‐(+)‐2,2′‐bis­(di­phenyl­phosphino)‐1,1′‐bi­naphthyl (BINAP) with tert‐butyl hydro­peroxide in toluene solution. The angle between the naphthyl planes of the bi­naphthyl group is 94.17 (3)°.     

(4R,4aR,6S,7S,7aS)‐6‐Hydro­xy‐7‐hy­droxy­methyl‐4‐methyl­per­hydro­cyclo­penta­[c]­pyran‐1‐one chloro­form solvate from Valeriana laxiflora

The structure of an iridolactone isolated from Valeriana laxiflora was established as (4R,4aR,6S,7S,7aS)‐6‐hydroxy‐7‐hydroxy­methyl‐4‐methyl­per­hydro­cyclo­penta­[c]­pyran‐1‐one chloro­form solvate, C₁₀H₁₆O₄·CHCl₃. The two rings are cis‐fused. The δ‐lactone ring adopts a slightly twisted half‐chair conformation with approximate planarity of the lactone group and the cyclo­pentane ring adopts an envelope conformation. The hydroxy group, the hydroxymethyl group and the methyl group all have β orientations. The absolute configuration was determined using anomalous dispersion data enhanced by the adventitious inclusion of a chloro­form solvent mol­ecule. Hydro­gen bonding, crystal packing and ring conformations are discussed in detail.     

Methyl 4‐amino‐2,3‐dihydro‐6‐methoxy‐1,3‐dioxo‐1H‐pyrrolo[3,4‐c]pyridine‐7‐carboxylate forms hydrogen‐bonded sheets built from R22(8) and R66(42) rings

In the title compound, C₁₀H₉N₃O₅, which was formed by the reaction of 6‐amino‐2‐methoxy‐4(3H)‐pyrimidinone with di­methyl acetyl­enedi­carboxyl­ate, the mol­ecules are linked by N—H?O hydrogen bonds [N?O 2.8974 (15) and 3.0300 (15) Å, and N—H?O 165 and 174°] into planar sheets built from alternating R₂²(8) and R₆⁶(42) rings.     

(3R*,4R*)‐3‐Iso­propyl‐4‐phenyl­azetidin‐2‐one at 150 K

The title compound, C₁₂H₁₅NO, crystallized in the centrosymmetric space group C2/c with one mol­ecule as the asymmetric unit. There is a single conventional N—H?O hydrogen bond, with a donor–acceptor distance of 2.912 (1) Å, which forms an R(8) cyclic dimer about a center of symmetry. There is a single significant intermolecular C—H?O interaction, which also forms an R(8) cyclic dimer about a center of symmetry. Taken together, these interactions form chains propagating along [110]. Structural comparisons are made with another β‐­lactam, (1′R*,3R*,4S*)‐3‐(1′‐hydroxy­ethyl)‐4‐phenylazet­id­in‐2‐one.     

[(1R,2R)‐1,2‐Di­amino­cyclo­hexane‐κ2N,N′](α‐di­imine‐κ2N,N′)­platinum(II) bis­(hexa­fluoro­phosphate), where α‐di­imine is 2,2′‐bi­pyridine and 1,10‐phen­anthroline

The title Pt^II complexes, viz. (2,2′‐bi­pyridine‐κ²N,N′)[(1R,2R)‐1,2‐di­amino­cyclo­hexane‐κ²N,N′]­platinum(II) bis­(hexa­fluoro­phosphate), [Pt(C₆H₁₄N₂)(C₁₀H₈N₂)](PF₆)₂, and [(1R,2R)‐1,2‐di­amino­cyclo­hexane‐κ²N,N′](1,10‐phenanthroline‐κ²N,N′)platinum(II) bis­(hexa­fluoro­phosphate), [Pt(C₆H₁₄N₂)(C₁₂H₈N₂)](PF₆)₂, containing an aromatic α‐di­imine and a non‐planar di­amino­cyclo­hexane, both form a ladder‐type structure, which is constructed via loose π–π stacking on the α‐di­imine ligands and hydrogen bonding between the cyclic amines and the counter‐anions. In the former compound, there are two independent complex cations, both of which have a twofold axis through the Pt atom.     

Conformational change induced by hydration: trans‐dichloro­bis­[(1R,2R,3R,5S)‐(–)‐isopinocampheylamine]palladium(II) and trans‐dichloro­bis[(1S,2S,3S,5R)‐(+)‐isopinocampheylamine]palladium(II) hemihydrate

The title compounds, trans‐dichloro­bis[(1R,2R,3R,5S)‐(−)‐2,6,6‐trimethyl­bicyclo­[3.1.1]heptan‐3‐amine]palladium(II), [PdCl₂(C₁₀H₁₉N)₂], and trans‐dichloro­bis[(1S,2S,3S,5R)‐(+)‐2,6,6‐trimethyl­bicyclo­[3.1.1]heptan‐3‐amine]palladium(II) hemihydrate, [PdCl₂(C₁₀H₁₉N)₂]·0.5H₂O, present different arrangements of the amine ligands coordinated to Pd^II, viz. antiperiplanar in the former case and (−)anticlinal in the latter. The hemihydrate is an inclusion compound, with a Pd coordination complex and disordered water mol­ecules residing on crystallographic twofold axes. The crystal structure for the hemihydrate includes a short Pd⋯Pd separation of 3.4133 (13) Å.     

(1R,2R)‐1,2‐Di­phenyl‐1,2‐bis(8‐quinoline­sulfonyl­amino)ethyl­enedi­amine–acetone (1/1)

The crystal structure of the new chiral complex (1R,2R)‐1,2‐di­phenyl‐1,2‐bis(8‐quinoline­sulfonyl­amino)‐ ethyl­enedi­amine–acetone (1/1), C₃₂H₂₆N₄O₄S₂^.C₃H₆O, is reported. The conformation of the C₃₂H₂₆N₄O₄S₂ (BQSDA) mol­ecule is determined by a bifurcated N—H?N hydrogen‐bond system. The acetone of solvation is linked to the BQSDA mol­ecule by an N—H?O hydrogen bond.     

Two 2,2‐dihalo‐N‐(1‐phenyl­ethyl)­cyclo­propane‐1‐carbox­amides

The crystal structures of (1R,1′S)‐2′,2′‐di­chloro‐N‐(1‐phenyl­ethyl)­cyclo­propane‐1′‐carbox­amide, C₁₂H₁₃Cl₂NO, (I), and (1R,1′R)‐2′,2′‐di­fluoro‐N‐(1‐phenyl­ethyl)­cyclo­propane‐1′‐car­box­amide, C₁₂H₁₃F₂NO, (II), have been determined. Both crystals contain two independent mol­ecules with different conformations of the phenyl­ethyl groups. In the crystals of both compounds, the mol­ecules are linked together by N—H⃛O hydrogen bonds, thus forming chains in the a direction.     

tert‐Butyl (6S)‐4‐hydroxy‐6‐isobutyl‐2‐oxo‐1,2,5,6‐tetra­hydropyridine‐1‐carboxyl­ate and tert‐butyl (4R,6S)‐4‐hydroxy‐6‐iso­butyl‐2‐oxopiperidine‐1‐carboxyl­ate

X‐ray studies reveal that tert‐butyl (6S)‐6‐iso­butyl‐2,4‐dioxo­piperidine‐1‐carboxyl­ate occurs in the 4‐enol form, viz. tert‐butyl (6S)‐4‐hydroxy‐6‐iso­butyl‐2‐oxo‐1,2,5,6‐tetra­hydropyri­dine‐1‐carboxyl­ate, C₁₄H₂₃NO₄, when crystals are grown from a mixture of di­chloro­methane and pentane, and has an axial orientation of the iso­butyl side chain at the 6‐position of the piperidine ring. Reduction of the keto functionality leads predominantly to the corresponding β‐hydroxy­lated δ‐lactam, tert‐butyl (4R,6S)‐4‐hydroxy‐6‐iso­butyl‐2‐oxo­piperidine‐1‐car­boxyl­ate, C₁₄H₂₅NO₄, with a cis configuration of the 4‐hydroxy and 6‐iso­butyl groups. The two compounds show similar molecular packing driven by strong O—H⋯O=C hydrogen bonds, leading to infinite chains in the crystal structure.